Efficacy and Safety of Ranibizumab for the Treatment of Choroidal Neovascularization due to Uncommon Cause: Twelve-Month Results of the MINERVA Study - Lai, T YY; Staurenghi, G; Lanzetta, P (Retina, 2018)